Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Change in Accured Expenses (2020 - 2026)

Rani Therapeutics Holdings' Change in Accured Expenses history spans 7 years, with the latest figure at $763000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 348.82% to $763000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.8 million, a 1137.64% increase, with the full-year FY2025 number at $3.2 million, up 809.71% from a year prior.
  • Change in Accured Expenses came in at $763000.0 for Q1 2026, down from $3.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.2 million in Q4 2025, with the low at -$2.2 million in Q4 2023.
  • Historically, Change in Accured Expenses has averaged $256588.2 across 5 years, with a median of $323000.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 693.67% in 2024 and later skyrocketed 998.96% in 2025.
  • Year by year, Change in Accured Expenses stood at -$1.8 million in 2022, then dropped by 21.46% to -$2.2 million in 2023, then soared by 113.33% to $289000.0 in 2024, then soared by 998.96% to $3.2 million in 2025, then crashed by 75.98% to $763000.0 in 2026.
  • Business Quant data shows Change in Accured Expenses for RANI at $763000.0 in Q1 2026, $3.2 million in Q4 2025, and -$550000.0 in Q3 2025.